Correlation Between Mendus AB and AroCell AB

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mendus AB and AroCell AB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mendus AB and AroCell AB into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mendus AB and AroCell AB, you can compare the effects of market volatilities on Mendus AB and AroCell AB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mendus AB with a short position of AroCell AB. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mendus AB and AroCell AB.

Diversification Opportunities for Mendus AB and AroCell AB

-0.22
  Correlation Coefficient

Very good diversification

The 3 months correlation between Mendus and AroCell is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Mendus AB and AroCell AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AroCell AB and Mendus AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mendus AB are associated (or correlated) with AroCell AB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AroCell AB has no effect on the direction of Mendus AB i.e., Mendus AB and AroCell AB go up and down completely randomly.

Pair Corralation between Mendus AB and AroCell AB

Assuming the 90 days trading horizon Mendus AB is expected to under-perform the AroCell AB. But the stock apears to be less risky and, when comparing its historical volatility, Mendus AB is 1.71 times less risky than AroCell AB. The stock trades about -0.12 of its potential returns per unit of risk. The AroCell AB is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  43.00  in AroCell AB on September 14, 2024 and sell it today you would lose (2.00) from holding AroCell AB or give up 4.65% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Mendus AB  vs.  AroCell AB

 Performance 
       Timeline  
Mendus AB 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Mendus AB are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Mendus AB may actually be approaching a critical reversion point that can send shares even higher in January 2025.
AroCell AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AroCell AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Mendus AB and AroCell AB Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mendus AB and AroCell AB

The main advantage of trading using opposite Mendus AB and AroCell AB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mendus AB position performs unexpectedly, AroCell AB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AroCell AB will offset losses from the drop in AroCell AB's long position.
The idea behind Mendus AB and AroCell AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume